News Release Details
Entegris Reports Results for Second Quarter of 2019
- Second-quarter revenue of
$378.9 million , decreased 1%from prior year - GAAP net income per diluted share of
$0.91 - Non-GAAP net income per diluted share of
$0.39 - Implementing operating model improvements expected to yield more than
$20 million of annualized cost savings
Second-quarter sales were
Mr. Loy added: "
Quarterly Financial Results Summary
(in thousands, except per share data)
GAAP Results |
Q2 2019 |
Q2 2018 |
Q1 2019 |
|||
Net sales |
$378,874 |
$383,059 |
$391,047 |
|||
Operating income |
$54,909 |
$74,933 |
$47,491 |
|||
Operating margin |
14.5% |
19.6% |
12.1% |
|||
Net income |
$123,997 |
$54,349 |
$32,658 |
|||
Diluted earnings per share (EPS) |
$0.91 |
$0.38 |
$0.24 |
|||
Non-GAAP Results |
||||||
Non-GAAP adjusted operating income |
$76,793 |
$93,473 |
$92,180 |
|||
Non-GAAP adjusted operating margin |
20.3% |
24.4% |
23.6% |
|||
Non-GAAP net income |
$53,432 |
$69,835 |
$67,894 |
|||
Non-GAAP EPS |
$0.39 |
$0.49 |
$0.50 |
Third-Quarter Outlook
For the third quarter ending
Organizational Changes
Segment Results
Specialty Chemicals and Engineered Materials (SCEM): SCEM provides high-performance and high-purity process chemistries, gases and materials, as well as safe and efficient delivery systems to support semiconductor and other advanced manufacturing processes.
Microcontamination Control (MC): MC solutions purify critical liquid chemistries and gases used in semiconductor manufacturing processes and other high-technology industries.
Advanced Materials Handling (AMH): AMH develops solutions to monitor, protect, transport, and deliver critical liquid chemistries, wafers, and substrates for a broad set of applications in the semiconductor industry and other high-technology industries.
Change in Inter-Segment Reporting
In the first quarter of 2019, the Company changed its definition of segment profit to include inter-segment sales. The Company updated its recognition of inter-segment sales to recognize the revenue and profit associated with products and components produced in one segment and supplied to another, before being sold to the ultimate end customer. The Company accounts for inter-segment sales and transfers as if the sales or transfers were to third parties, that is, at approximate market prices. Prior quarter information was recast to reflect the change in the Company’s definition of segment profit.
Second-Quarter Results Conference Call Details
The call can also be accessed live and on-demand from the
Management’s slide presentation concerning the results for the second quarter, which may be referred to during the call, will be posted on the investor relations section of www.entegris.com Thursday morning before the call.
ABOUT
Non-GAAP Information
The Company’s condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe,” “expect,” “anticipate,” “intends,” “estimate,” “forecast,” “project,” “should,” “may,” “will,” “would” or the negative thereof and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include statements related to future period guidance; future sales, net income, net income per diluted share, non-GAAP EPS, non-GAAP net income, expenses and other financial metrics; our performance relative to our markets; the impact, financial or otherwise, of any organizational changes; market and technology trends; the development of new products and the success of their introductions; Company's capital allocation strategy, which may be modified at any time for any reason, including share repurchases, dividends, debt repayments and potential acquisitions; the effect of the Tax Cuts and Jobs Act on our capital allocation strategy; the impact of the acquisitions we have made and commercial partnerships we have established; our ability to execute on our strategies; and other matters. These statements involve risks and uncertainties, and actual results may differ. These risks and uncertainties include, but are not limited to, weakening of global and/or regional economic conditions, generally or specifically in the semiconductor industry, which could decrease the demand for our products and solutions; our ability to meet rapid demand shifts; our ability to continue technological innovation and introduce new products to meet our customers' rapidly changing requirements; our concentrated customer base; our ability to identify, effect and integrate acquisitions, joint ventures or other transactions; our ability to effectively implement any organizational changes; our ability to protect and enforce intellectual property rights; operational, political and legal risks of our international operations; our dependence on sole source and limited source suppliers; the increasing complexity of certain manufacturing processes; raw material shortages and price increases; changes in government regulations of the countries in which we operate; fluctuation of currency exchange rates; fluctuations in the market price of Entegris’ stock; the level of, and obligations associated with, our indebtedness; and other risk factors and additional information described in our filings with the
Condensed Consolidated Statements of Operations
(In thousands, except per share data)
(Unaudited)
|
Three months ended |
||||||||
|
June 29, 2019 |
June 30, 2018 |
March 30, 2019 |
||||||
Net sales |
$ |
378,874 |
|
$ |
383,059 |
|
$ |
391,047 |
|
Cost of sales |
212,600 |
|
200,681 |
|
213,654 |
|
|||
Gross profit |
166,274 |
|
182,378 |
|
177,393 |
|
|||
Selling, general and administrative expenses |
64,150 |
|
65,200 |
|
82,254 |
|
|||
Engineering, research and development expenses |
30,624 |
|
30,231 |
|
28,991 |
|
|||
Amortization of intangible assets |
16,591 |
|
12,014 |
|
18,657 |
|
|||
Operating income |
54,909 |
|
74,933 |
|
47,491 |
|
|||
Interest expense, net |
9,692 |
|
6,925 |
|
9,659 |
|
|||
Other (income) expense, net |
(122,015 |
) |
3,877 |
|
(248 |
) |
|||
Income before income tax expense |
167,232 |
|
64,131 |
|
38,080 |
|
|||
Income tax expense |
43,235 |
|
9,782 |
|
5,422 |
|
|||
Net income |
$ |
123,997 |
|
$ |
54,349 |
|
$ |
32,658 |
|
|
|
|
|
||||||
|
|
|
|||||||
Basic net income per common share: |
$ |
0.92 |
|
$ |
0.38 |
|
$ |
0.24 |
|
Diluted net income per common share: |
$ |
0.91 |
|
$ |
0.38 |
|
$ |
0.24 |
|
|
|
|
|
||||||
Weighted average shares outstanding: |
|
|
|
||||||
Basic |
135,378 |
|
141,701 |
|
135,299 |
|
|||
Diluted |
136,581 |
|
143,238 |
|
136,692 |
|
Condensed Consolidated Statements of Operations
(In thousands, except per share data)
(Unaudited)
|
Six months ended |
|||||
|
June 29, 2019 |
June 30, 2018 |
||||
Net sales |
$ |
769,921 |
|
$ |
750,258 |
|
Cost of sales |
426,254 |
|
391,883 |
|
||
Gross profit |
343,667 |
|
358,375 |
|
||
Selling, general and administrative expenses |
146,404 |
|
123,469 |
|
||
Engineering, research and development expenses |
59,615 |
|
57,817 |
|
||
Amortization of intangible assets |
35,248 |
|
23,683 |
|
||
Operating income |
102,400 |
|
153,406 |
|
||
Interest expense, net |
19,351 |
|
14,151 |
|
||
Other (income) expense, net |
(122,263 |
) |
4,016 |
|
||
Income before income tax expense |
205,312 |
|
135,239 |
|
||
Income tax expense |
48,657 |
|
23,328 |
|
||
Net income |
$ |
156,655 |
|
$ |
111,911 |
|
|
|
|
||||
|
|
|||||
Basic net income per common share: |
$ |
1.16 |
|
$ |
0.79 |
|
Diluted net income per common share: |
$ |
1.15 |
|
$ |
0.78 |
|
|
|
|
||||
Weighted average shares outstanding: |
|
|
||||
Basic |
135,338 |
|
141,641 |
|
||
Diluted |
136,637 |
|
143,445 |
|
Condensed Consolidated Balance Sheets
(In thousands)
(Unaudited)
|
June 29, 2019 |
December 31, 2018 |
||||
ASSETS |
|
|
||||
Cash and cash equivalents |
$ |
521,382 |
|
$ |
482,062 |
|
Trade accounts and notes receivable, net |
218,682 |
|
222,055 |
|
||
Inventories, net |
261,934 |
|
268,140 |
|
||
Deferred tax charges and refundable income taxes |
18,741 |
|
17,393 |
|
||
Other current assets |
27,715 |
|
39,688 |
|
||
Total current assets |
1,048,454 |
|
1,029,338 |
|
||
|
|
|
||||
Property, plant and equipment, net |
445,254 |
|
419,529 |
|
||
|
|
|
||||
Right-of-use assets |
44,176 |
|
— |
|
||
Goodwill |
583,328 |
|
550,202 |
|
||
Intangible assets |
266,425 |
|
295,687 |
|
||
Deferred tax assets and other noncurrent tax assets |
23,153 |
|
10,162 |
|
||
Other |
13,932 |
|
12,723 |
|
||
Total assets |
$ |
2,424,722 |
|
$ |
2,317,641 |
|
|
|
|
||||
LIABILITIES AND SHAREHOLDERS’ EQUITY |
|
|||||
Long-term debt, current maturities |
4,000 |
|
4,000 |
|
||
Accounts payable |
56,986 |
|
93,055 |
|
||
Accrued liabilities |
117,783 |
|
141,020 |
|
||
Income tax payable |
36,371 |
|
31,593 |
|
||
Total current liabilities |
215,140 |
|
269,668 |
|
||
|
|
|
||||
Long-term debt, excluding current maturities |
933,675 |
|
934,863 |
|
||
Long-term lease liability |
40,612 |
|
— |
|
||
Other liabilities |
132,746 |
|
101,085 |
|
||
Shareholders’ equity |
1,102,549 |
|
1,012,025 |
|
||
Total liabilities and shareholders’ equity |
$ |
2,424,722 |
|
$ |
2,317,641 |
|
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
|
Three months ended |
Six months ended |
||||||||||
|
June 29, 2019 |
June 30, 2018 |
June 29, 2019 |
June 30, 2018 |
||||||||
Operating activities: |
|
|
|
|
||||||||
Net income |
$ |
123,997 |
|
$ |
54,349 |
|
$ |
156,655 |
|
$ |
111,911 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
||||||||
Depreciation |
18,596 |
|
15,802 |
|
35,317 |
|
31,699 |
|
||||
Amortization |
16,591 |
|
12,014 |
|
35,248 |
|
23,683 |
|
||||
Stock-based compensation expense |
4,936 |
|
4,429 |
|
9,589 |
|
8,557 |
|
||||
Other |
446 |
|
2,101 |
|
6,140 |
|
2,883 |
|
||||
Changes in operating assets and liabilities: |
|
|
|
|
||||||||
Trade accounts and notes receivable |
14,545 |
|
8,698 |
|
5,436 |
|
2,687 |
|
||||
Inventories |
5,840 |
|
(7,517 |
) |
3,709 |
|
(22,472 |
) |
||||
Accounts payable and accrued liabilities |
(7,688 |
) |
19,019 |
|
(52,707 |
) |
(14,966 |
) |
||||
Income taxes payable and refundable income taxes |
58,264 |
|
(14,207 |
) |
15,391 |
|
(7,515 |
) |
||||
Other |
(4,626 |
) |
3,601 |
|
13,585 |
|
639 |
|
||||
Net cash provided by operating activities |
230,901 |
|
98,289 |
|
228,363 |
|
137,106 |
|
||||
Investing activities: |
|
|
|
|
||||||||
Acquisition of property and equipment |
(25,636 |
) |
(26,390 |
) |
(60,101 |
) |
(47,437 |
) |
||||
Acquisition of businesses, net of cash acquired |
522 |
|
(342,569 |
) |
(49,267 |
) |
(380,225 |
) |
||||
Other |
— |
|
1,759 |
|
197 |
|
1,905 |
|
||||
Net cash used in investing activities |
(25,114 |
) |
(367,200 |
) |
(109,171 |
) |
(425,757 |
) |
||||
Financing activities: |
|
|
|
|
||||||||
Payments on long-term debt |
(1,000 |
) |
(2,000 |
) |
(2,000 |
) |
(27,000 |
) |
||||
Issuance of common stock |
— |
|
2,554 |
|
917 |
|
3,027 |
|
||||
Taxes paid related to net share settlement of equity awards |
(574 |
) |
(290 |
) |
(8,301 |
) |
(14,413 |
) |
||||
Repurchase and retirement of common stock |
(15,000 |
) |
(10,000 |
) |
(50,321 |
) |
(20,000 |
) |
||||
Dividend payments |
(9,494 |
) |
(9,919 |
) |
(18,964 |
) |
(19,802 |
) |
||||
Other |
(247 |
) |
1,750 |
|
(497 |
) |
1,504 |
|
||||
Net cash used in financing activities |
(26,315 |
) |
(17,905 |
) |
(79,166 |
) |
(76,684 |
) |
||||
Effect of exchange rate changes on cash |
(450 |
) |
(6,314 |
) |
(706 |
) |
(2,967 |
) |
||||
Increase (decrease) in cash and cash equivalents |
179,022 |
|
(293,130 |
) |
39,320 |
|
(368,302 |
) |
||||
Cash and cash equivalents at beginning of period |
342,360 |
|
550,236 |
|
482,062 |
|
625,408 |
|
||||
Cash and cash equivalents at end of period |
$ |
521,382 |
|
$ |
257,106 |
|
$ |
521,382 |
|
$ |
257,106 |
|
Segment Information
(In thousands)
(Unaudited)
Note: In the first quarter of 2019, the Company has changed its definition of segment profit to include inter-segment sales. The Company updated its recognition of inter-segment sales to recognize the revenue and profit associated with products and components produced in one segment and supplied to another, before being sold to the ultimate end customer. The Company accounts for inter-segment sales and transfers as if the sales or transfers were to third parties, that is, at approximate market prices. Inter-segment sales are presented as an elimination below. Prior quarter information was recast to reflect the change in the Company’s definition of segment profit.
|
Three months ended |
|
Six months ended |
|||||||||||||
Net sales |
June 29, 2019 |
June 30, 2018 |
March 30, 2019 |
|
June 29, 2019 |
June 30, 2018 |
||||||||||
Specialty Chemicals and Engineered Materials |
$ |
127,552 |
|
$ |
134,336 |
|
$ |
124,470 |
|
|
$ |
252,022 |
|
$ |
265,079 |
|
Microcontamination Control |
150,185 |
|
124,937 |
|
157,706 |
|
|
307,891 |
|
243,860 |
|
|||||
Advanced Materials Handling |
107,515 |
|
130,572 |
|
116,064 |
|
|
223,579 |
|
254,650 |
|
|||||
Inter-segment elimination |
(6,378 |
) |
(6,786 |
) |
(7,193 |
) |
|
(13,571 |
) |
(13,331 |
) |
|||||
Total net sales |
$ |
378,874 |
|
$ |
383,059 |
|
$ |
391,047 |
|
|
$ |
769,921 |
|
$ |
750,258 |
|
|
Three months ended |
|
Six months ended |
|||||||||||||
Segment profit |
June 29, 2019 |
June 30, 2018 |
March 30, 2019 |
|
June 29, 2019 |
June 30, 2018 |
||||||||||
Specialty Chemicals and Engineered Materials |
$ |
24,000 |
|
$ |
36,728 |
|
$ |
24,431 |
|
|
$ |
48,431 |
|
$ |
67,649 |
|
Microcontamination Control |
43,126 |
|
37,214 |
|
47,323 |
|
|
90,449 |
|
77,525 |
|
|||||
Advanced Materials Handling |
15,043 |
|
25,542 |
|
22,367 |
|
|
37,410 |
|
51,005 |
|
|||||
Total segment profit |
82,169 |
|
99,484 |
|
94,121 |
|
|
176,290 |
|
196,179 |
|
|||||
Amortization of intangible assets |
16,591 |
|
12,014 |
|
18,657 |
|
|
35,248 |
|
23,683 |
|
|||||
Unallocated expenses |
10,669 |
|
12,537 |
|
27,973 |
|
|
38,642 |
|
19,090 |
|
|||||
Total operating income |
$ |
54,909 |
|
$ |
74,933 |
|
$ |
47,491 |
|
|
$ |
102,400 |
|
$ |
153,406 |
|
Reconciliation of GAAP Gross Profit to Adjusted Gross Profit
(In thousands)
(Unaudited)
|
Three months ended |
|
Six months ended |
|||||||||||||
|
June 29, 2019 |
June 30, 2018 |
March 30, 2019 |
|
June 29, 2019 |
June 30, 2018 |
||||||||||
Net sales |
$ |
378,874 |
|
$ |
383,059 |
|
$ |
391,047 |
|
|
$ |
769,921 |
|
$ |
750,258 |
|
Gross profit-GAAP |
$ |
166,274 |
|
$ |
182,378 |
|
$ |
177,393 |
|
|
$ |
343,667 |
|
$ |
358,375 |
|
Adjustments to gross profit: |
|
|
|
|
|
|
||||||||||
Severance and restructuring costs |
— |
|
— |
|
358 |
|
|
358 |
|
— |
|
|||||
Charge for fair value mark-up of acquired inventory sold |
695 |
|
208 |
|
2,155 |
|
|
2,850 |
|
208 |
|
|||||
Adjusted gross profit |
$ |
166,969 |
|
$ |
182,586 |
|
$ |
179,906 |
|
|
$ |
346,875 |
|
$ |
358,583 |
|
|
|
|
|
|
|
|
||||||||||
Gross margin - as a % of net sales |
43.9 |
% |
47.6 |
% |
45.4 |
% |
|
44.6 |
% |
47.8 |
% |
|||||
Adjusted gross margin - as a % of net sales |
44.1 |
% |
47.7 |
% |
46.0 |
% |
|
45.1 |
% |
47.8 |
% |
Reconciliation of GAAP Segment Profit to Adjusted Operating Income
(In thousands)
(Unaudited)
Note: In the first quarter of 2019, the Company has changed its definition of segment profit to include inter-segment sales. The Company updated its recognition of inter-segment sales to recognize the revenue and profit associated with products and components produced in one segment and supplied to another, before being sold to the ultimate end customer. The Company accounts for inter-segment sales and transfers as if the sales or transfers were to third parties, that is, at approximate market prices. Prior quarter information was recast to reflect the change in the Company’s definition of segment profit.
|
Three months ended |
|
Six months ended |
|||||||||||||
Segment profit-GAAP |
June 29, 2019 |
June 30, 2018 |
March 30, 2019 |
|
June 29, 2019 |
June 30, 2018 |
||||||||||
Specialty Chemicals and Engineered Materials |
$ |
24,000 |
|
$ |
36,728 |
|
$ |
24,431 |
|
|
$ |
48,431 |
|
$ |
67,649 |
|
Microcontamination Control |
43,126 |
|
37,214 |
|
47,323 |
|
|
90,449 |
|
77,525 |
|
|||||
Advanced Materials Handling |
15,043 |
|
25,542 |
|
22,367 |
|
|
37,410 |
|
51,005 |
|
|||||
Total segment profit |
82,169 |
|
99,484 |
|
94,121 |
|
|
176,290 |
|
196,179 |
|
|||||
Amortization of intangible assets |
16,591 |
|
12,014 |
|
18,657 |
|
|
35,248 |
|
23,683 |
|
|||||
Unallocated expenses |
10,669 |
|
12,537 |
|
27,973 |
|
|
38,642 |
|
19,090 |
|
|||||
Total operating income |
$ |
54,909 |
|
$ |
74,933 |
|
$ |
47,491 |
|
|
$ |
102,400 |
|
$ |
153,406 |
|
|
Three months ended |
|
Six months ended |
|||||||||||||
Adjusted segment profit |
June 29, 2019 |
June 30, 2018 |
March 30, 2019 |
|
June 29, 2019 |
June 30, 2018 |
||||||||||
Specialty Chemicals and Engineered Materials1 |
$ |
24,695 |
|
$ |
36,728 |
|
$ |
25,070 |
|
|
$ |
49,765 |
|
$ |
67,649 |
|
Microcontamination Control 2 |
43,126 |
|
37,422 |
|
50,082 |
|
|
93,208 |
|
77,733 |
|
|||||
Advanced Materials Handling 3 |
15,043 |
|
25,542 |
|
22,945 |
|
|
37,988 |
|
51,005 |
|
|||||
Total adjusted segment profit |
82,864 |
|
99,692 |
|
98,097 |
|
|
180,961 |
|
196,387 |
|
|||||
Amortization of intangible assets4 |
— |
|
— |
|
— |
|
|
— |
|
— |
|
|||||
Unallocated expenses5 |
6,071 |
|
6,219 |
|
5,917 |
|
|
11,988 |
|
12,772 |
|
|||||
Total adjusted operating income |
$ |
76,793 |
|
$ |
93,473 |
|
$ |
92,180 |
|
|
$ |
168,973 |
|
$ |
183,615 |
|
1 Adjusted segment profit for Specialty Chemicals and Engineered Materials for the three months ended
2 Adjusted segment profit for Microcontamination Control for the three and six months ended
3Adjusted segment profit for Advanced Materials Handling for the three months ended
4 Adjusted amortization of intangible assets excludes amortization expense of
5 Adjusted unallocated expenses for the three months ended
Reconciliation of GAAP Net Income to Adjusted Operating Income and Adjusted EBITDA
(In thousands)
(Unaudited)
|
Three months ended |
|
Six months ended |
|||||||||||||
|
June 29, 2019 |
June 30, 2018 |
March 30, 2019 |
|
June 29, 2019 |
June 30, 2018 |
||||||||||
Net sales |
$ |
378,874 |
|
$ |
383,059 |
|
$ |
391,047 |
|
|
$ |
769,921 |
|
$ |
750,258 |
|
Net income |
$ |
123,997 |
|
$ |
54,349 |
|
$ |
32,658 |
|
|
$ |
156,655 |
|
$ |
111,911 |
|
Adjustments to net income: |
|
|
|
|
|
|
||||||||||
Income tax expense |
43,235 |
|
9,782 |
|
5,422 |
|
|
48,657 |
|
23,328 |
|
|||||
Interest expense, net |
9,692 |
|
6,925 |
|
9,659 |
|
|
19,351 |
|
14,151 |
|
|||||
Other (income) expense, net |
(122,015 |
) |
3,877 |
|
(248 |
) |
|
(122,263 |
) |
4,016 |
|
|||||
GAAP - Operating income |
54,909 |
|
74,933 |
|
47,491 |
|
|
102,400 |
|
153,406 |
|
|||||
Charge for fair value write-up of acquired inventory sold |
695 |
|
208 |
|
2,155 |
|
|
2,850 |
|
208 |
|
|||||
Deal costs |
1,164 |
|
5,121 |
|
19,136 |
|
|
20,300 |
|
5,121 |
|
|||||
Integration costs |
1,264 |
|
1,197 |
|
2,920 |
|
|
4,184 |
|
1,197 |
|
|||||
Severance and restructuring costs |
2,170 |
|
— |
|
1,821 |
|
|
3,991 |
|
— |
|
|||||
Amortization of intangible assets |
16,591 |
|
12,014 |
|
18,657 |
|
|
35,248 |
|
23,683 |
|
|||||
Adjusted operating income |
76,793 |
|
93,473 |
|
92,180 |
|
|
168,973 |
|
183,615 |
|
|||||
Depreciation |
18,596 |
|
15,802 |
|
16,721 |
|
|
35,317 |
|
31,699 |
|
|||||
Adjusted EBITDA |
$ |
95,389 |
|
$ |
109,275 |
|
$ |
108,901 |
|
|
$ |
204,290 |
|
$ |
215,314 |
|
|
|
|
|
|
|
|
||||||||||
Adjusted operating margin |
20.3 |
% |
24.4 |
% |
23.6 |
% |
|
21.9 |
% |
24.5 |
% |
|||||
Adjusted EBITDA - as a % of net sales |
25.2 |
% |
28.5 |
% |
27.8 |
% |
|
26.5 |
% |
28.7 |
% |
Reconciliation of GAAP Net Income to Non-GAAP Earnings per Share
(In thousands, except per share data)
(Unaudited)
|
Three months ended |
|
Six months ended |
|||||||||||||
|
June 29, 2019 |
June 30, 2018 |
March 30, 2019 |
|
June 29, 2019 |
June 30, 2018 |
||||||||||
GAAP net income |
$ |
123,997 |
|
$ |
54,349 |
|
$ |
32,658 |
|
|
$ |
156,655 |
|
$ |
111,911 |
|
Adjustments to net income: |
|
|
|
|
|
|
||||||||||
Charge for fair value write-up of acquired inventory sold |
695 |
|
208 |
|
2,155 |
|
|
2,850 |
|
208 |
|
|||||
Deal costs |
1,164 |
|
5,121 |
|
19,547 |
|
|
20,711 |
|
5,121 |
|
|||||
Integration costs |
1,264 |
|
1,197 |
|
2,920 |
|
|
4,184 |
|
1,197 |
|
|||||
Severance and restructuring costs |
2,170 |
|
— |
|
1,821 |
|
|
3,991 |
|
— |
|
|||||
Versum termination fee, net |
(122,000 |
) |
— |
|
— |
|
|
(122,000 |
) |
— |
|
|||||
Amortization of intangible assets |
16,591 |
|
12,014 |
|
18,657 |
|
|
35,248 |
|
23,683 |
|
|||||
Tax effect of legal entity restructuring |
9,398 |
|
— |
|
— |
|
|
9,398 |
|
— |
|
|||||
Tax effect of adjustments to net income and discrete items1 |
20,153 |
|
(3,702 |
) |
(9,864 |
) |
|
10,289 |
|
(6,412 |
) |
|||||
Tax effect of Tax Cuts and Jobs Act |
— |
|
648 |
|
— |
|
|
— |
|
2,142 |
|
|||||
Non-GAAP net income |
$ |
53,432 |
|
$ |
69,835 |
|
$ |
67,894 |
|
|
$ |
121,326 |
|
$ |
137,850 |
|
|
|
|
|
|
|
|
||||||||||
Diluted earnings per common share |
$ |
0.91 |
|
$ |
0.38 |
|
$ |
0.24 |
|
|
$ |
1.15 |
|
$ |
0.78 |
|
Effect of adjustments to net income |
$ |
(0.52 |
) |
$ |
0.11 |
|
$ |
0.26 |
|
|
$ |
(0.26 |
) |
$ |
0.18 |
|
Diluted non-GAAP earnings per common share |
$ |
0.39 |
|
$ |
0.49 |
|
$ |
0.50 |
|
|
$ |
0.89 |
|
$ |
0.96 |
|
1The tax effect of pre-tax adjustments to net income was calculated using the applicable marginal tax rate during the respective years.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190725005142/en/
Source:
Bill Seymour
VP of Investor Relations
T + 1 952 556 1844